Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

Simple item page
dc.contributor.authorPablo Arab, Juan
dc.contributor.authorDirchwolf, Melisa
dc.contributor.authorAlvares-da-Silva, Mario Reis
dc.contributor.authorBarrera, Francisco
dc.contributor.authorBenitez, Carlos
dc.contributor.authorCastellanos-Fernandez, Marlene
dc.contributor.authorCastro-Narro, Graciela
dc.contributor.authorChavez-Tapia, Norberto
dc.contributor.authorChiodi, Daniela
dc.contributor.authorCotrim, Helma
dc.contributor.authorCusi, Kenneth
dc.contributor.authorMarques Souza de Oliveira, Claudia Pinto
dc.contributor.authorDiaz, Javier
dc.contributor.authorFassio, Eduardo
dc.contributor.authorGerona, Solange
dc.contributor.authorGirala, Marcos
dc.contributor.authorHernandez, Nelia
dc.contributor.authorMarciano, Sebastian
dc.contributor.authorMasson, Walter
dc.contributor.authorMendez-Sanchez, Nahum
dc.contributor.authorLeite, Nathalie
dc.contributor.authorLozano, Adelina
dc.contributor.authorPadilla, Martin
dc.contributor.authorPanduro, Arturo
dc.contributor.authorParana, Raymundo
dc.contributor.authorParise, Edison
dc.contributor.authorPerez, Marlene
dc.contributor.authorPoniachik, Jaime
dc.contributor.authorCarlos Restrepo, Juan
dc.contributor.authorRuf, Andres
dc.contributor.authorSilva, Marcelo
dc.contributor.authorTagle, Martin
dc.contributor.authorTapias, Monica
dc.contributor.authorTorres, Kenia
dc.contributor.authorVilar-Gomez, Eduardo
dc.contributor.authorCosta Gil, Jose Eduardo
dc.contributor.authorGadano, Adrian
dc.contributor.authorArrese, Marco
dc.date.accessioned2025-01-23T19:47:02Z
dc.date.available2025-01-23T19:47:02Z
dc.date.issued2020
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociacion Latinoamericana para el Estudio del Higado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease, written by Latin-American specialists in different clinical areas, and destined to general practitioners, internal medicine specialists, endocrinologists, diabetologists, gastroenterologists, and hepatologists. The main purpose of this document is to improve patient care and awareness of NAFLD. The information provided in this guidance may also be useful in assisting stakeholders in the decision-making process related to NAFLD. Since new evidence is constantly emerging on different aspects of the disease, updates to this guideline will be required in future. (C) 2020 Published by Elsevier Espana, S.L.U. on behalf of Fundacion Cilnica Medica Sur, A.C.
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.aohep.2020.09.006
dc.identifier.issn1665-2681
dc.identifier.urihttps://doi.org/10.1016/j.aohep.2020.09.006
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/100342
dc.identifier.wosidWOS:000585342300017
dc.issue.numero6
dc.language.isoen
dc.pagina.final690
dc.pagina.inicio674
dc.revistaAnnals of hepatology
dc.rightsacceso restringido
dc.subjectSteatosis
dc.subjectNAFLD
dc.subjectNASH
dc.subjectFatty liver
dc.subjectClinical practice guidance
dc.subjectNonalcoholic fatty liver disease
dc.subjectNonalcoholic steatohepatitis
dc.subjectMAFLD
dc.subjectCirrhosis
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleLatin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
dc.typeartículo
dc.volumen19
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas